Robin Gasiorowski

7PUBLICATIONS
39CO-AUTHORS
Instruments and techniquesPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.

Harry J Iland, John Reynolds, Alan V Boddy

|Sep 25, 2024
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial.

Catherine Thieblemont, Yasmin H Karimi, Herve Ghesquieres

|Dec 22, 2022
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial.

Catherine Thieblemont, Tycel Phillips, Herve Ghesquieres

|Aug 25, 2022
CAR-T for follicular lymphoma: are we good to go?

Robin Gasiorowski, Judith Trotman

|Apr 23, 2022
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma.

Jonathan Wong, Emily Gruber, Belinda Maher

|Oct 13, 2021
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma.

Pier Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro

Pageof 2

Frequent Collaborators

2 joint publications

Judith Trotman

2 joint publications

Chan Y Cheah

2 joint publications

Michael Dickinson

2 joint publications

Tae Min Kim